Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
11,674
archived clinical trials in
Skin Cancer

Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes
A Phase 3, Prospective, Open-Label, Multicenter Comparison Study of Lymphoseek® and Vital Blue Dye as Lymphoid Tissue Targeting Agents in Patients With Known Melanoma or Breast Cancer Who Are Undergoing Lymph Node Mapping
Status: Archived
Ohio State University
mi
from
Columbus, OH
Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes
A Phase 3, Prospective, Open-Label, Multicenter Comparison Study of Lymphoseek® and Vital Blue Dye as Lymphoid Tissue Targeting Agents in Patients With Known Melanoma or Breast Cancer Who Are Undergoing Lymph Node Mapping
Status: Archived
Updated: 1/1/1970
Ohio State University
mi
from
Columbus, OH
Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic Melanoma
Phase I Study To Evaluate Cellular Adoptive Immunotherapy Using Autologous IL-21 Modulated CD8+ Antigen-Specific T Cells For Patients With Metastatic Melanoma
Status: Archived
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic Melanoma
Phase I Study To Evaluate Cellular Adoptive Immunotherapy Using Autologous IL-21 Modulated CD8+ Antigen-Specific T Cells For Patients With Metastatic Melanoma
Status: Archived
Updated: 1/1/1970
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Providence Cancer Center at Providence Hospital
mi
from
Mobile, AL
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Providence Cancer Center at Providence Hospital
mi
from
Mobile, AL
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Arizona Cancer Center, University of Arizona
mi
from
Tucson, AZ
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Arizona Cancer Center, University of Arizona
mi
from
Tucson, AZ
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Poudre Valley Hospital
mi
from
Fort Collins, CO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Poudre Valley Hospital
mi
from
Fort Collins, CO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Saint Anthony's Hospital at Saint Anthony's Health Center
mi
from
Alton, IL
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Saint Anthony's Hospital at Saint Anthony's Health Center
mi
from
Alton, IL
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
University of Chicago
mi
from
Chicago, IL
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
University of Chicago
mi
from
Chicago, IL
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Decatur Memorial Hospital Cancer Care Institute
mi
from
Decatur, IL
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Decatur Memorial Hospital Cancer Care Institute
mi
from
Decatur, IL
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Good Samaritan Regional Health Center
mi
from
Mount Vernon, IL
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Good Samaritan Regional Health Center
mi
from
Mount Vernon, IL
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Memorial Health System
mi
from
Springfield, IL
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Memorial Health System
mi
from
Springfield, IL
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
St. Francis Hospital & Health Centers
mi
from
Michigan City, IN
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
St. Francis Hospital & Health Centers
mi
from
Michigan City, IN
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Reid Hospital & Health Care Services
mi
from
Richmond, IN
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Reid Hospital & Health Care Services
mi
from
Richmond, IN
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Genesis Health System
mi
from
Davenport, IA
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Genesis Health System
mi
from
Davenport, IA
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Lawrence Memorial Hospital
mi
from
Lawrence, KA
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Lawrence Memorial Hospital
mi
from
Lawrence, KA
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Menorah Medical Center
mi
from
Overland Park, KA
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Menorah Medical Center
mi
from
Overland Park, KA
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
St Luke'S Hospital And Health Network
mi
from
Bethlehem, PA
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
St Luke'S Hospital And Health Network
mi
from
Bethlehem, PA
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Shawnee Mission Hospital
mi
from
Shawnee Mission, KA
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Shawnee Mission Hospital
mi
from
Shawnee Mission, KA
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Wesley Medical Center
mi
from
Wichita, KA
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Wesley Medical Center
mi
from
Wichita, KA
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Battle Creek Health System Cancer Care Center
mi
from
Battle Creek, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Battle Creek Health System Cancer Care Center
mi
from
Battle Creek, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Mecosta County Medical Center
mi
from
Big Rapids, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Mecosta County Medical Center
mi
from
Big Rapids, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
CCOP - Grand Rapids Clinical Oncology Program
mi
from
Grand Rapids, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
CCOP - Grand Rapids Clinical Oncology Program
mi
from
Grand Rapids, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Spectrum Health Butterworth Hospital
mi
from
Grand Rapids, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Spectrum Health Butterworth Hospital
mi
from
Grand Rapids, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Lacks Cancer Center at Saint Mary's Health Care
mi
from
Grand Rapids, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Lacks Cancer Center at Saint Mary's Health Care
mi
from
Grand Rapids, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Mercy General Health Partners
mi
from
Muskegon, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Mercy General Health Partners
mi
from
Muskegon, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Munson Medical Center
mi
from
Traverse City, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Munson Medical Center
mi
from
Traverse City, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Metro Health Hospital
mi
from
Wyoming, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Metro Health Hospital
mi
from
Wyoming, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
University of Mississippi
mi
from
Jackson, MS
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
University of Mississippi
mi
from
Jackson, MS
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Central Care Cancer Center at Carrie J. Babb Cancer Center
mi
from
Bolivar, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Central Care Cancer Center at Carrie J. Babb Cancer Center
mi
from
Bolivar, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Skaggs Cancer Center at Skaggs Regional Medical Center
mi
from
Branson, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Skaggs Cancer Center at Skaggs Regional Medical Center
mi
from
Branson, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Saint Francis Medical Center
mi
from
Cape Girardeau, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Saint Francis Medical Center
mi
from
Cape Girardeau, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
St. Joseph Medical Center
mi
from
Kansas City, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
St. Joseph Medical Center
mi
from
Kansas City, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Truman Medical Center
mi
from
Kansas City, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Truman Medical Center
mi
from
Kansas City, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Research Medical Center
mi
from
Kansas City, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Research Medical Center
mi
from
Kansas City, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
CCOP - Kansas City
mi
from
Kansas City, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
CCOP - Kansas City
mi
from
Kansas City, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
North Kansas City Hospital
mi
from
Kansas City, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
North Kansas City Hospital
mi
from
Kansas City, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Parvin Radiation Oncology
mi
from
Kansas City, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Parvin Radiation Oncology
mi
from
Kansas City, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Saint Luke's East - Lee's Summit
mi
from
Lee's Summit, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Saint Luke's East - Lee's Summit
mi
from
Lee's Summit, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Liberty Hospital
mi
from
Liberty, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Liberty Hospital
mi
from
Liberty, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Heartland Regional Medical Center
mi
from
Saint Joseph, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Heartland Regional Medical Center
mi
from
Saint Joseph, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
David Fivenson, M.D. Dermatology, PLLC
mi
from
Ann Arbor, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
David Fivenson, M.D. Dermatology, PLLC
mi
from
Ann Arbor, MI
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
CCOP - St. Louis-Cape Girardeau
mi
from
Saint Louis, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
CCOP - St. Louis-Cape Girardeau
mi
from
Saint Louis, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
St. John's Pediatrics
mi
from
Leavenworth, KA
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
St. John's Pediatrics
mi
from
Leavenworth, KA
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Hulston Cancer Center at Cox Medical Center South
mi
from
Springfield, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Hulston Cancer Center at Cox Medical Center South
mi
from
Springfield, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
CCOP - Cancer Research for the Ozarks
mi
from
Springfield, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
CCOP - Cancer Research for the Ozarks
mi
from
Springfield, MO
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Billings Clinic - Downtown
mi
from
Billings, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Billings Clinic - Downtown
mi
from
Billings, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
St. Vincent Healthcare Cancer Care Services
mi
from
Billings, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
St. Vincent Healthcare Cancer Care Services
mi
from
Billings, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Montana Cancer Consortium CCOP
mi
from
Billings, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Montana Cancer Consortium CCOP
mi
from
Billings, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Hematology-Oncolgy Associates of NNJ-PA
mi
from
Denville, NJ
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Hematology-Oncolgy Associates of NNJ-PA
mi
from
Denville, NJ
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Bozeman Deaconess Cancer Center
mi
from
Bozeman, MT
RO4929097 in Treating Patients With Stage IV Melanoma
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Status: Archived
Updated: 1/1/1970
Bozeman Deaconess Cancer Center
mi
from
Bozeman, MT